Función de CCR5 y sus ligandos en la respuesta del sistema inmune adaptativo frente a tumores
Author
González Martín, AliciaEntity
UAM. Departamento de Biología MolecularDate
2009-07-20Subjects
Quimioquinas - Receptores - Tesis doctorales; Biología y Biomedicina / BiologíaNote
Tesis doctoral inédita leída en la Universidad Autónoma de Madrid, Facultad de Ciencias, Departamento de Biología Molecular. Fecha de lectura: 20-07-2009Abstract
The chemokine receptor CCR5 and its ligands have been implicated in tumor
pathogenesis although it is unclear whether they promote or restrict cancer progression.
Our aim is to determine the role of CCR5 in controlling tumor progression, focusing
specially on the function of this receptor in the T cell response to the tumor. To address
this issue, we analyzed the in vivo contribution of CCR5 to cancer in four different
animal models. In a first approach, we modulated the levels of CCR5 ligands secreted
by tumor cells injected subcutaneously into syngeneic CCR5 KO or wild-type mice.
Stable silencing or overexpression of CCR5 agonists resulted in an enhanced or reduced
tumor growth rate, respectively, compared to mock cells expressing low amounts of
CCR5 ligands. This effect was observed when syngeneic tumors were injected into
CCR5-expressing mice, but not in CCR5 KO and RAG-2 immunodeficient mice. We
also observed subtle CCL5/CCR5 expression-dependent changes in leukocyte
infiltration of tumors.
To further analyze CCR5 function in the T cell-mediated immune response to tumor
antigens, we generated OVA-specific, TCR transgenic CD8 and CD4 cells (OT1/OT2),
that did or did not express CCR5. Our data demonstrate that CCR5 expression in both
CD8 and CD4 antigen-specific T cells is necessary for effective rejection of
subcutaneously-transplanted, OVA-expressing tumors. Analysis of T cell proliferation,
activation and migration revealed the importance of CCR5 in CD8 T cell infiltration
into the tumor parenchyma. Finally, we assessed the CCR5 contribution to tumor onset
and development in two models of tumorigenesis: the transgenic MMTV-Her2/neu
mouse model, which generates spontaneous mammary tumors at 8-9 months of age, and
the methylcholantrene (MCA)-induced fibrosarcoma model. Onset, incidence and
growth of MCA-induced fibrosarcomas were significantly decreased in CCR5 WT
compared to CCR5 KO mice. We also found differences in the onset and incidence of
the mammary tumors in FVB-C57BL/6 MMTVneu mice bearing a single transgene
copy; these differences were lost in FVB-C57BL/6 MMTVneu mice with two transgene
copies or when backcrossed into a FVB background. Our results suggest that CCR5 has
an important role in tumor immunosurveillance in specific circumstances, which most
likely favors a cooperative tumor-specific response by CD4 and CD8 T cells.
Files in this item
Google Scholar:González Martín, Alicia
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Respuesta inmune generada por sistemas combinados de vacunación frente a péptidos de la envuelta del VIH-1 incluidos en la proteína multiepitópica TAB13
Gómez Rodríguez, Carmen Elena
2003-12-17